UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial

Ultrasound in obstetrics & gynecology, 2009-02, Vol.33 (2), p.142-146

2009

Volltextzugriff (PDF)

Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening

BJOG : an international journal of obstetrics and gynaecology, 1999-12, Vol.106 (12), p.1304-1306

1999

Volltextzugriff (PDF)

Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies

Obstetrics and gynecology (New York. 1953), 1997-07, Vol.90 (1), p.98-101

1997

Volltextzugriff (PDF)

Prenatal Screening for Down's Syndrome with Use of Maternal Serum Markers

The New England journal of medicine, 1992-08, Vol.327 (9), p.588-593

1992

Volltextzugriff (PDF)

Clinical Outcomes of Human papillomavirus (HPV) Testing Discordance in Oropharyngeal Squamous cell Carcinoma

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.e17-e17

2024

Volltextzugriff (PDF)

First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study

Prenatal diagnosis, 2006-08, Vol.26 (8), p.672-678

2006

Volltextzugriff (PDF)

Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies

American journal of obstetrics and gynecology, 1999-05, Vol.180 (5), p.1131-1137

1999

Volltextzugriff (PDF)

Inhibin A measurement using an automated assay platform

Prenatal diagnosis, 2008-05, Vol.28 (5), p.399-403

2008

Volltextzugriff (PDF)

First-trimester screening for aneuploidy: Research or standard of care?

American journal of obstetrics and gynecology, 2000-03, Vol.182 (3), p.490-496

2000

Volltextzugriff (PDF)

Maternal serum screening for Down's syndrome in early pregnancy

BMJ, 1988-10, Vol.297 (6653), p.883-887

1988

Volltextzugriff (PDF)

DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study

Genetics in medicine, 2011-11, Vol.13 (11), p.913-920

2011

Volltextzugriff (PDF)

DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study

Genetics in medicine, 2012-03, Vol.14 (3), p.296-305

2012

Volltextzugriff (PDF)

Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies

Obstetrics and gynecology (New York. 1953), 2000-02, Vol.95 (2), p.227-231

2000

Volltextzugriff (PDF)

Inhibins and activins in human fetal abnormalities

Molecular and cellular endocrinology, 2004-10, Vol.225 (1), p.101-108

2004

Volltextzugriff (PDF)

Amniotic fluid insulin at 14-20 weeks' gestation: association with later maternal glucose intolerance and birth macrosomia

Diabetes care, 2001-07, Vol.24 (7), p.1259-1263

2001

Volltextzugriff (PDF)

Multiple Immunoreactive Inhibin Proteins in Serum from Postmenopausal Women with Epithelial Ovarian Cancer

Gynecologic oncology, 1997-06, Vol.65 (3), p.512-516

1997

Volltextzugriff (PDF)

Undetectable maternal serum unconjugated estriol levels in the second trimester: Risk of perinatal complications associated with placental sulfatase deficiency

American journal of obstetrics and gynecology, 1997-03, Vol.176 (3), p.531-535

1997

Volltextzugriff (PDF)

Fetal neural tube defects: maternal serum and amniotic fluid activin A levels

Prenatal diagnosis, 2004-07, Vol.24 (7), p.574-575

2004

Volltextzugriff (PDF)

Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin

Prenatal diagnosis, 1995-08, Vol.15 (8), p.713-723

1995

Volltextzugriff (PDF)

Cortisol levels predict cognitive impairment induced by electroconvulsive therapy

Biological psychiatry (1969), 2001-09, Vol.50 (5), p.331-336

2001

Volltextzugriff (PDF)

Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops

Prenatal diagnosis, 1998-10, Vol.18 (10), p.1061-1067

1998

Volltextzugriff (PDF)

Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome

BJOG : an international journal of obstetrics and gynaecology, 1988-04, Vol.95 (4), p.330-333

1988

Volltextzugriff (PDF)

Antidepressant and Cognition-Enhancing Effects of DHEA in Major Depression

Annals of the New York Academy of Sciences, 1995-12, Vol.774 (1), p.337-339

1995

Volltextzugriff (PDF)

First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome

The New England journal of medicine, 2005-11, Vol.353 (19), p.2001-2011

2005

Volltextzugriff (PDF)

The accuracy of assigned risks in maternal serum screening

Prenatal diagnosis, 1998-04, Vol.18 (4), p.413-415

1998

Volltextzugriff (PDF)

1 – 25 von 200

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(186)
Mit Volltextzugriff
(157)

Publikationsform

Sprache

Englisch
(200)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial

Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening

Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies

Prenatal Screening for Down's Syndrome with Use of Maternal Serum Markers

Clinical Outcomes of Human papillomavirus (HPV) Testing Discordance in Oropharyngeal Squamous cell Carcinoma

First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study

Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies

Inhibin A measurement using an automated assay platform

First-trimester screening for aneuploidy: Research or standard of care?

Maternal serum screening for Down's syndrome in early pregnancy

DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study

DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study

Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies

Inhibins and activins in human fetal abnormalities

Amniotic fluid insulin at 14-20 weeks' gestation: association with later maternal glucose intolerance and birth macrosomia

Multiple Immunoreactive Inhibin Proteins in Serum from Postmenopausal Women with Epithelial Ovarian Cancer

Undetectable maternal serum unconjugated estriol levels in the second trimester: Risk of perinatal complications associated with placental sulfatase deficiency

Fetal neural tube defects: maternal serum and amniotic fluid activin A levels

Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin

Cortisol levels predict cognitive impairment induced by electroconvulsive therapy

Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops

Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome

Antidepressant and Cognition-Enhancing Effects of DHEA in Major Depression

First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome

The accuracy of assigned risks in maternal serum screening

Suchergebnisse filtern